APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lacosamide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lacosamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchLacosamide Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Lacosamide Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Lacosamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lacosamide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Lacosamide Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Lacosamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Lacosamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lacosamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lacosamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lacosamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lacosamide include UCB, Teva, Sun Pharma, Mylan, MSN Laboratories, Glenmark, Aurobindo Pharma, Apotex and Amneal Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Lacosamide market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lacosamide and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lacosamide revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lacosamide market size, projected growth trends, production technologies, key applications, and end-use industries.

Lacosamide Segment by Company

UCB

Teva

Sun Pharma

Mylan

MSN Laboratories

Glenmark

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Alembic Pharma

Accord Healthcare

Lacosamide Segment by Type

Intravenous

Oral tablets

Oral solution

Lacosamide Segment by Application

Adults

Pediatric patients

Lacosamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lacosamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lacosamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lacosamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lacosamide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lacosamide industry.

Chapter 3: Detailed analysis of Lacosamide companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lacosamiderevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lacosamide Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Intravenous Table 3. Key Players of Oral tablets Table 4. Key Players of Oral solution Table 4. Global Lacosamide Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Adults Table 6. Key Players of Pediatric patients Table 7. Global Lacosamide Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Lacosamide Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Lacosamide Market Share by Region (2021-2026) Table 10. Global Lacosamide Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Lacosamide Market Share by Region (2027-2032) Table 12. Lacosamide Industry Trends Table 13. Lacosamide Industry Drivers Table 14. Lacosamide Industry Opportunities and Challenges Table 15. Lacosamide Industry Restraints Table 16. Global Lacosamide Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Lacosamide Revenue Market Share by Company (2021-2026) Table 18. Global Lacosamide Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Lacosamide Key Company Head Office and Area Served Table 20. Global Lacosamide Company, Product Type & Application Table 21. Global Lacosamide Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Lacosamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Lacosamide Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lacosamide Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Lacosamide Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Lacosamide Revenue Market Share by Type (2021-2026) Table 28. Global Lacosamide Revenue Market Share by Type (2027-2032) Table 29. Global Lacosamide Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lacosamide Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Lacosamide Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Lacosamide Revenue Market Share by Application (2021-2026) Table 33. Global Lacosamide Revenue Market Share by Application (2027-2032) Table 34. UCB Company Information Table 35. UCB Business Overview Table 36. UCB Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. UCB Lacosamide Product Portfolio Table 38. UCB Recent Development Table 39. Teva Company Information Table 40. Teva Business Overview Table 41. Teva Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teva Lacosamide Product Portfolio Table 43. Teva Recent Development Table 44. Sun Pharma Company Information Table 45. Sun Pharma Business Overview Table 46. Sun Pharma Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sun Pharma Lacosamide Product Portfolio Table 48. Sun Pharma Recent Development Table 49. Mylan Company Information Table 50. Mylan Business Overview Table 51. Mylan Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Mylan Lacosamide Product Portfolio Table 53. Mylan Recent Development Table 54. MSN Laboratories Company Information Table 55. MSN Laboratories Business Overview Table 56. MSN Laboratories Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. MSN Laboratories Lacosamide Product Portfolio Table 58. MSN Laboratories Recent Development Table 59. Glenmark Company Information Table 60. Glenmark Business Overview Table 61. Glenmark Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Glenmark Lacosamide Product Portfolio Table 63. Glenmark Recent Development Table 64. Aurobindo Pharma Company Information Table 65. Aurobindo Pharma Business Overview Table 66. Aurobindo Pharma Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Aurobindo Pharma Lacosamide Product Portfolio Table 68. Aurobindo Pharma Recent Development Table 69. Apotex Company Information Table 70. Apotex Business Overview Table 71. Apotex Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Apotex Lacosamide Product Portfolio Table 73. Apotex Recent Development Table 74. Amneal Pharmaceuticals Company Information Table 75. Amneal Pharmaceuticals Business Overview Table 76. Amneal Pharmaceuticals Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Amneal Pharmaceuticals Lacosamide Product Portfolio Table 78. Amneal Pharmaceuticals Recent Development Table 79. Alembic Pharma Company Information Table 80. Alembic Pharma Business Overview Table 81. Alembic Pharma Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Alembic Pharma Lacosamide Product Portfolio Table 83. Alembic Pharma Recent Development Table 84. Accord Healthcare Company Information Table 85. Accord Healthcare Business Overview Table 86. Accord Healthcare Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Accord Healthcare Lacosamide Product Portfolio Table 88. Accord Healthcare Recent Development Table 89. North America Lacosamide Market Size by Type (2021-2026) & (US$ Million) Table 90. North America Lacosamide Market Size by Type (2027-2032) & (US$ Million) Table 91. North America Lacosamide Market Size by Application (2021-2026) & (US$ Million) Table 92. North America Lacosamide Market Size by Application (2027-2032) & (US$ Million) Table 93. North America Lacosamide Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Lacosamide Market Size by Country (2021-2026) Table 95. North America Lacosamide Market Size by Country (2027-2032) Table 96. Europe Lacosamide Market Size by Type (2021-2026) & (US$ Million) Table 97. Europe Lacosamide Market Size by Type (2027-2032) & (US$ Million) Table 98. Europe Lacosamide Market Size by Application (2021-2026) & (US$ Million) Table 99. Europe Lacosamide Market Size by Application (2027-2032) & (US$ Million) Table 100. Europe Lacosamide Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Lacosamide Market Size by Country (2021-2026) Table 102. Europe Lacosamide Market Size by Country (2027-2032) Table 103. China Lacosamide Market Size by Type (2021-2026) & (US$ Million) Table 104. China Lacosamide Market Size by Type (2027-2032) & (US$ Million) Table 105. China Lacosamide Market Size by Application (2021-2026) & (US$ Million) Table 106. China Lacosamide Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Lacosamide Market Size by Type (2021-2026) & (US$ Million) Table 108. Asia Lacosamide Market Size by Type (2027-2032) & (US$ Million) Table 109. Asia Lacosamide Market Size by Application (2021-2026) & (US$ Million) Table 110. Asia Lacosamide Market Size by Application (2027-2032) & (US$ Million) Table 111. Asia Lacosamide Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Lacosamide Market Size by Country (2021-2026) Table 113. Asia Lacosamide Market Size by Country (2027-2032) Table 114. South America, Middle East & Africa Lacosamide Market Size by Type (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa Lacosamide Market Size by Type (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa Lacosamide Market Size by Application (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Lacosamide Market Size by Application (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Lacosamide Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. South America, Middle East & Africa Lacosamide Market Size by Country (2021-2026) Table 120. South America, Middle East & Africa Lacosamide Market Size by Country (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Lacosamide Product Image Figure 2. Global Lacosamide Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Lacosamide Market Share by Type: 2025 VS 2032 Figure 4. Intravenous Image Figure 5. Oral tablets Image Figure 6. Oral solution Image Figure 7. Global Lacosamide Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Lacosamide Market Share by Application: 2025 VS 2032 Figure 9. Adults Image Figure 10. Pediatric patients Image Figure 11. Global Lacosamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lacosamide Market Size (2021-2032) & (US$ Million) Figure 13. Global Lacosamide Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Lacosamide Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Lacosamide Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Lacosamide Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Lacosamide Revenue Market Share by Type (2021-2032) Figure 20. Global Lacosamide Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Lacosamide Revenue Market Share by Application (2021-2032) Figure 22. North America Lacosamide Market Size (2021-2032) & (US$ Million) Figure 23. North America Lacosamide Market Share by Type (2021-2032) Figure 24. North America Lacosamide Market Share by Application (2021-2032) Figure 25. North America Lacosamide Market Share by Country (2021-2032) Figure 26. United States Lacosamide Market Size (2021-2032) & (US$ Million) Figure 27. Canada Lacosamide Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Lacosamide Market Size (2021-2032) & (US$ Million) Figure 29. Europe Lacosamide Market Size (2021-2032) & (US$ Million) Figure 30. Europe Lacosamide Market Share by Type (2021-2032) Figure 31. Europe Lacosamide Market Share by Application (2021-2032) Figure 32. Europe Lacosamide Market Share by Country (2021-2032) Figure 33. Germany Lacosamide Market Size (2021-2032) & (US$ Million) Figure 34. France Lacosamide Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Lacosamide Market Size (2021-2032) & (US$ Million) Figure 36. Italy Lacosamide Market Size (2021-2032) & (US$ Million) Figure 37. Russia Lacosamide Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Lacosamide Market Size (2021-2032) & (US$ Million) Figure 39. China Lacosamide Market Size (2021-2032) & (US$ Million) Figure 40. China Lacosamide Market Share by Type (2021-2032) Figure 41. China Lacosamide Market Share by Application (2021-2032) Figure 42. Asia Lacosamide Market Size (2021-2032) & (US$ Million) Figure 43. Asia Lacosamide Market Share by Type (2021-2032) Figure 44. Asia Lacosamide Market Share by Application (2021-2032) Figure 45. Asia Lacosamide Market Share by Country (2021-2032) Figure 46. Japan Lacosamide Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Lacosamide Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Lacosamide Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Lacosamide Market Size (2021-2032) & (US$ Million) Figure 50. India Lacosamide Market Size (2021-2032) & (US$ Million) Figure 51. Australia Lacosamide Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Lacosamide Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Lacosamide Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Lacosamide Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Lacosamide Market Share by Country (2021-2032) Figure 56. Brazil Lacosamide Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Lacosamide Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Lacosamide Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Lacosamide Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Lacosamide Market Size (2021-2032) & (US$ Million) Figure 61. UAE Lacosamide Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Lacosamide Market Size (2021-2032) & (US$ Million) Figure 63. Chile Lacosamide Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous
  • Oral tablets
  • Oral solution
Applications
  • Adults
  • Pediatric patients
Companies covered
  • UCB
  • Teva
  • Sun Pharma
  • Mylan
  • MSN Laboratories
  • Glenmark
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Alembic Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Lacosamide Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Intravenous
  5. 1.2.3 Oral tablets
  6. 1.2.4 Oral solution
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Lacosamide Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Adults
  10. 1.3.3 Pediatric patients
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Lacosamide Growth Trends by Region
  13. 1.5.1 Global Lacosamide Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Lacosamide Market Size by Region (2021-2026)
  15. 1.5.3 Lacosamide Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Lacosamide Market Dynamics
  1. 2.1 Lacosamide Industry Trends
  2. 2.2 Lacosamide Industry Drivers
  3. 2.3 Lacosamide Industry Opportunities and Challenges
  4. 2.4 Lacosamide Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Lacosamide Revenue by Company (2021-2026)
  2. 3.2 Global Lacosamide Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Lacosamide Key Company Head office and Area Served
  4. 3.4 Global Lacosamide Company, Product Type & Application
  5. 3.5 Global Lacosamide Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Lacosamide Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Lacosamide Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Lacosamide Tier 1, Tier 2, and Tier 3
4 Lacosamide Market by Type
  1. 4.1 Global Lacosamide Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Lacosamide Market Size by Type (2021-2032)
  3. 4.3 Global Lacosamide Market Size Share by Type (2021-2032)
5 Lacosamide Market by Application
  1. 5.1 Global Lacosamide Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Lacosamide Market Size by Application (2021-2032)
  3. 5.3 Global Lacosamide Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 UCB
  2. 6.1.1 UCB Company Information
  3. 6.1.2 UCB Business Overview
  4. 6.1.3 UCB Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 UCB Lacosamide Product Portfolio
  6. 6.1.5 UCB Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Lacosamide Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sun Pharma
  14. 6.3.1 Sun Pharma Company Information
  15. 6.3.2 Sun Pharma Business Overview
  16. 6.3.3 Sun Pharma Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sun Pharma Lacosamide Product Portfolio
  18. 6.3.5 Sun Pharma Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mylan Lacosamide Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 MSN Laboratories
  26. 6.5.1 MSN Laboratories Company Information
  27. 6.5.2 MSN Laboratories Business Overview
  28. 6.5.3 MSN Laboratories Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 MSN Laboratories Lacosamide Product Portfolio
  30. 6.5.5 MSN Laboratories Recent Developments
  31. 6.6 Glenmark
  32. 6.6.1 Glenmark Company Information
  33. 6.6.2 Glenmark Business Overview
  34. 6.6.3 Glenmark Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Glenmark Lacosamide Product Portfolio
  36. 6.6.5 Glenmark Recent Developments
  37. 6.7 Aurobindo Pharma
  38. 6.7.1 Aurobindo Pharma Company Information
  39. 6.7.2 Aurobindo Pharma Business Overview
  40. 6.7.3 Aurobindo Pharma Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Aurobindo Pharma Lacosamide Product Portfolio
  42. 6.7.5 Aurobindo Pharma Recent Developments
  43. 6.8 Apotex
  44. 6.8.1 Apotex Company Information
  45. 6.8.2 Apotex Business Overview
  46. 6.8.3 Apotex Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Apotex Lacosamide Product Portfolio
  48. 6.8.5 Apotex Recent Developments
  49. 6.9 Amneal Pharmaceuticals
  50. 6.9.1 Amneal Pharmaceuticals Company Information
  51. 6.9.2 Amneal Pharmaceuticals Business Overview
  52. 6.9.3 Amneal Pharmaceuticals Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Amneal Pharmaceuticals Lacosamide Product Portfolio
  54. 6.9.5 Amneal Pharmaceuticals Recent Developments
  55. 6.10 Alembic Pharma
  56. 6.10.1 Alembic Pharma Company Information
  57. 6.10.2 Alembic Pharma Business Overview
  58. 6.10.3 Alembic Pharma Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Alembic Pharma Lacosamide Product Portfolio
  60. 6.10.5 Alembic Pharma Recent Developments
  61. 6.11 Accord Healthcare
  62. 6.11.1 Accord Healthcare Company Information
  63. 6.11.2 Accord Healthcare Business Overview
  64. 6.11.3 Accord Healthcare Lacosamide Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Accord Healthcare Lacosamide Product Portfolio
  66. 6.11.5 Accord Healthcare Recent Developments
7 North America
  1. 7.1 North America Lacosamide Market Size (2021-2032)
  2. 7.2 North America Lacosamide Market Size by Type
  3. 7.2.1 North America Lacosamide Market Size by Type (2021-2026)
  4. 7.2.2 North America Lacosamide Market Size by Type (2027-2032)
  5. 7.2.3 North America Lacosamide Market Share by Type (2021-2032)
  6. 7.3 North America Lacosamide Market Size by Application
  7. 7.3.1 North America Lacosamide Market Size by Application (2021-2026)
  8. 7.3.2 North America Lacosamide Market Size by Application (2027-2032)
  9. 7.3.3 North America Lacosamide Market Share by Application (2021-2032)
  10. 7.4 North America Lacosamide Market Size by Country
  11. 7.4.1 North America Lacosamide Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Lacosamide Market Size by Country (2021-2026)
  13. 7.4.3 North America Lacosamide Market Size by Country (2027-2032)
  14. 7.4.4 North America Lacosamide Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Lacosamide Market Size (2021-2032)
  2. 8.2 Europe Lacosamide Market Size by Type
  3. 8.2.1 Europe Lacosamide Market Size by Type (2021-2026)
  4. 8.2.2 Europe Lacosamide Market Size by Type (2027-2032)
  5. 8.2.3 Europe Lacosamide Market Share by Type (2021-2032)
  6. 8.3 Europe Lacosamide Market Size by Application
  7. 8.3.1 Europe Lacosamide Market Size by Application (2021-2026)
  8. 8.3.2 Europe Lacosamide Market Size by Application (2027-2032)
  9. 8.3.3 Europe Lacosamide Market Share by Application (2021-2032)
  10. 8.4 Europe Lacosamide Market Size by Country
  11. 8.4.1 Europe Lacosamide Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Lacosamide Market Size by Country (2021-2026)
  13. 8.4.3 Europe Lacosamide Market Size by Country (2027-2032)
  14. 8.4.4 Europe Lacosamide Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Lacosamide Market Size (2021-2032)
  2. 9.2 China Lacosamide Market Size by Type
  3. 9.2.1 China Lacosamide Market Size by Type (2021-2026)
  4. 9.2.2 China Lacosamide Market Size by Type (2027-2032)
  5. 9.2.3 China Lacosamide Market Share by Type (2021-2032)
  6. 9.3 China Lacosamide Market Size by Application
  7. 9.3.1 China Lacosamide Market Size by Application (2021-2026)
  8. 9.3.2 China Lacosamide Market Size by Application (2027-2032)
  9. 9.3.3 China Lacosamide Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Lacosamide Market Size (2021-2032)
  2. 10.2 Asia Lacosamide Market Size by Type
  3. 10.2.1 Asia Lacosamide Market Size by Type (2021-2026)
  4. 10.2.2 Asia Lacosamide Market Size by Type (2027-2032)
  5. 10.2.3 Asia Lacosamide Market Share by Type (2021-2032)
  6. 10.3 Asia Lacosamide Market Size by Application
  7. 10.3.1 Asia Lacosamide Market Size by Application (2021-2026)
  8. 10.3.2 Asia Lacosamide Market Size by Application (2027-2032)
  9. 10.3.3 Asia Lacosamide Market Share by Application (2021-2032)
  10. 10.4 Asia Lacosamide Market Size by Country
  11. 10.4.1 Asia Lacosamide Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Lacosamide Market Size by Country (2021-2026)
  13. 10.4.3 Asia Lacosamide Market Size by Country (2027-2032)
  14. 10.4.4 Asia Lacosamide Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Lacosamide Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Lacosamide Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Lacosamide Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Lacosamide Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Lacosamide Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Lacosamide Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Lacosamide Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Lacosamide Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Lacosamide Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Lacosamide Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Lacosamide Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Lacosamide Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Lacosamide Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Lacosamide Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst